Item 16. Form 10-K Summary

3K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

None

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	ZIMMER BIOMET HOLDINGS, INC.

	By:	/s/ Ivan Tornos
Dated: February 23, 2024		Ivan Tornos
		President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


SIGNATURE	TITLE	DATE
/s/ Ivan Tornos	President, Chief Executive Officer and Director	February 23, 2024
Ivan Tornos	(Principal Executive Officer)

/s/ Suketu Upadhyay	Chief Financial Officer and Executive Vice President - Finance, Operations and Supply Chain	February 23, 2024
Suketu Upadhyay	(Principal Financial Officer)

/s/ Paul Stellato	Vice President, Controller and Chief Accounting	February 23, 2024
Paul Stellato	Officer (Principal Accounting Officer)

/s/ Christopher Begley	Director	February 23, 2024
Christopher Begley

/s/ Betsy Bernard	Director	February 23, 2024
Betsy Bernard

/s/ Michael Farrell	Director	February 23, 2024
Michael Farrell

/s/ Robert Hagemann	Director	February 23, 2024
Robert Hagemann

/s/ Arthur Higgins	Director	February 23, 2024
Arthur Higgins

/s/ Maria Teresa Hilado	Director	February 23, 2024
Maria Teresa Hilado

/s/ Syed Jafry	Director	February 23, 2024
Syed Jafry

/s/ Sreelakshmi Kolli	Director	February 23, 2024
Sreelakshmi Kolli

/s/ Michael Michelson	Director	February 23, 2024
Michael Michelson

/s/ Louis A. Shapiro	Director	February 23, 2024
Louis A. Shapiro

Previous: Item 15. Exhibits and Financial Statement Schedules